ClinConnect ClinConnect Logo
Search / Trial NCT07046052

PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

Launched by UNIVERSITY COLLEGE CORK · Jun 22, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Hip Fracture Regional Anaesthesia Analgesia Peng Block Continuous Infusion Programmed Intermittent Bolus Randomised Controlled Trial

ClinConnect Summary

This clinical trial is looking at the best way to manage pain after hip fracture surgery, specifically fractures near the top of the thigh bone (called the neck of femur). It compares two methods of delivering local anesthetic—a medicine that numbs the area—through a nerve block called the PENG block. One method gives the medicine continuously through a small tube, while the other gives doses at set times. The goal is to find out which method provides better pain relief after surgery.

The trial is open to adults over 18 who speak English and are having a specific type of hip surgery called hemiarthroplasty for a fractured neck of femur. To join, patients need to be able to give written consent and weigh more than 50 kilograms. People who have certain conditions like chronic pain, long-term opioid use, infections near the injection site, allergies to anesthetics, or blood clotting problems cannot take part. If you join, you will receive one of the two pain relief methods after your surgery, and the medical team will monitor how well it controls your pain. This study aims to help improve pain management for future patients with hip fractures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • English-speaking
  • over the age of 18 years
  • hemiarthroplasty for fractured neck of femur
  • able to provide written consent.
  • Exclusion Criteria:
  • under 50kg body weight.
  • unable to provide consent due to incapacity
  • pregnant women
  • vulnerable adults under state guardianship
  • Patients with pre-existing chronic pain disorders or with a history of long-term opioid use
  • those with contraindications to a peripheral nerve block such as local site infection, allergy to local anaesthetic or those who are coagulopathic

About University College Cork

University College Cork (UCC) is a leading research institution located in Ireland, renowned for its commitment to advancing healthcare through innovative clinical research. The university's clinical trial unit is dedicated to conducting high-quality, ethically sound studies that aim to improve patient outcomes and contribute to the scientific understanding of various medical conditions. UCC collaborates with a diverse network of healthcare professionals, researchers, and industry partners to facilitate pioneering trials across multiple therapeutic areas, ensuring adherence to the highest standards of regulatory compliance and patient safety. Through its initiatives, UCC strives to foster advancements in medicine and enhance the overall health of communities both locally and globally.

Locations

Cork, , Ireland

Patients applied

0 patients applied

Trial Officials

Benjamin P Atterton, MBChB FRCA

Study Director

Cork University Hospital & University College Cork

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported